Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid local infiltration versus intravenous injection in posterior lumbar fusion
TCTR20251117005Phase 4Active, not recruiting
- Sponsor
- Panlop Tirawanish
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tranexamic acid in postoperative hemorrhage (2 arms), sponsored by Panlop Tirawanish. Primary endpoint: Postoperative blood loss. Started Nov 2025; status: active, not recruiting.
02
Drugs
tranexamic acid
03
Conditions
postoperative hemorrhage
Beyond the preview
Go deeper on TCTR20251117005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251117005.